Cite
HARVARD Citation
Shachar, B. et al. (2020). Impact of 18F-fluorodeoxyglucose PET/CT in the management of patients with plasma cell disorders. Nuclear medicine communications. 41 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shachar, B. et al. (2020). Impact of 18F-fluorodeoxyglucose PET/CT in the management of patients with plasma cell disorders. Nuclear medicine communications. 41 (1), p. . [Online].